ResearcherNanjing General Hospital of Nanjing Military CommandNo recent work listed

Jing Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5957-981X; OpenAlex author ID A5100336764. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. Co-author DOI 10.3389/fonc.2021.767832 ↗
Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrence of pancreatic cancer. Co-author DOI 10.1016/j.tranon.2020.100818 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xixu Zhu · 2 shared papers, 2020–2021 · strength 0.29
- Paper Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. DOI 10.3389/fonc.2021.767832 ↗
- Paper Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrenc… DOI 10.1016/j.tranon.2020.100818 ↗
Xiaoqin Ji · 1 shared paper, 2021 · strength 0.15
- Paper Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. DOI 10.3389/fonc.2021.767832 ↗
Shenghua Jing · 1 shared paper, 2021 · strength 0.15
- Paper Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. DOI 10.3389/fonc.2021.767832 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.